{"id":132319,"name":"INOVIO PHARMACEUTICALS","slug":"inovio-pharmaceuticals","state":"PA","country":"United States of America","description":"Pharmaceuticals","totalSpending":550000,"filings":20,"yearlySpending":[{"year":2018,"income":150000},{"year":2019,"income":100000},{"year":2020,"income":90000},{"year":2021,"income":150000},{"year":2022,"income":60000}],"issues":[{"code":"PHA","display":"Pharmacy"},{"code":"HCR","display":"Health Issues"}],"firms":["MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)"],"lobbyists":["ROBERT WASINGER","MONA MOHIB","AMANDA ANDERSON"],"govEntities":["Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Government Relations Services including developing strategies to achieve legislative goals, inclusion of MERS on list of neglected diseases at FDA","Government Relations Services including developing strategies to achieve legislative goals, inclusion of MERS on list of neglected diseases at FDA","Government Relations Services including developing strategies to achieve legislative goals, inclusion of MERS on list of neglected diseases at FDA","Government Relations Services including developing strategies to achieve legislative goals, inclusion of MERS on list of neglected diseases at FDA","Government Relations Services including developing strategies to achieve legislative goals, inclusion of MERS on list of neglected diseases at FDA"]}